Ellis Bradley W, Acun Aylin, Can U Isik, Zorlutuna Pinar
Bioengineering Graduate Program, University of Notre Dame , Notre Dame, Indiana 46556, USA.
Aerospace and Mechanical Engineering Department, University of Notre Dame , Notre Dame, Indiana 46556, USA.
Biomicrofluidics. 2017 Mar 16;11(2):024105. doi: 10.1063/1.4978468. eCollection 2017 Mar.
The heart wall tissue, or the myocardium, is one of the main targets in cardiovascular disease prevention and treatment. Animal models have not been sufficient in mimicking the human myocardium as evident by the very low clinical translation rates of cardiovascular drugs. Additionally, current models of the human myocardium possess several shortcomings such as lack of physiologically relevant co-culture of myocardial cells, lack of a 3D biomimetic environment, and the use of non-human cells. In this study, we address these shortcomings through the design and manufacture of a myocardium-on-chip (MOC) using 3D cell-laden hydrogel constructs and human induced pluripotent stem cell (hiPSC) derived myocardial cells. The MOC utilizes 3D spatially controlled co-culture of hiPSC derived cardiomyocytes (iCMs) and hiPSC derived endothelial cells (iECs) integrated among iCMs as well as in capillary-like side channels, to better mimic the microvasculature seen in native myocardium. We first fully characterized iCMs using immunostaining, genetic, and electrochemical analysis and iECs through immunostaining and alignment analysis to ensure their functionality, and then seeded these cells sequentially into the MOC device. We showed that iECs could be cultured within the microfluidic device without losing their phenotypic lineage commitment, and align with the flow upon physiological level shear stresses. We were able to incorporate iCMs within the device in a spatially controlled manner with the help of photocrosslinkable polymers. The iCMs were shown to be viable and functional within the device up to 7 days, and were integrated with the iECs. The iCMs and iECs in this study were derived from the same hiPSC cell line, essentially mimicking the myocardium of an individual human patient. Such devices are essential for personalized medicine studies where the individual drug response of patients with different genetic backgrounds can be tested in a physiologically relevant manner.
心脏壁组织,即心肌,是心血管疾病预防和治疗的主要靶点之一。动物模型在模拟人类心肌方面并不充分,心血管药物极低的临床转化率就证明了这一点。此外,目前的人类心肌模型存在几个缺点,如缺乏心肌细胞生理相关的共培养、缺乏三维仿生环境以及使用非人类细胞。在本研究中,我们通过设计和制造一种芯片上的心肌(MOC)来解决这些缺点,该芯片使用负载细胞的三维水凝胶构建体和人诱导多能干细胞(hiPSC)衍生的心肌细胞。MOC利用hiPSC衍生的心肌细胞(iCMs)和hiPSC衍生的内皮细胞(iECs)在iCMs之间以及毛细血管样侧通道中进行三维空间控制的共培养,以更好地模拟天然心肌中的微血管系统。我们首先通过免疫染色、基因和电化学分析对iCMs进行了全面表征,并通过免疫染色和排列分析对iECs进行了表征,以确保它们的功能,然后将这些细胞依次接种到MOC装置中。我们表明,iECs可以在微流控装置中培养而不失去其表型谱系特征,并在生理水平的剪切应力作用下与流动方向对齐。在可光交联聚合物的帮助下,我们能够以空间控制的方式将iCMs整合到装置中。结果表明,iCMs在装置中可存活并发挥功能长达7天,并与iECs整合在一起。本研究中的iCMs和iECs来源于同一hiPSC细胞系,基本模拟了个体人类患者的心肌。此类装置对于个性化医学研究至关重要,在该研究中,可以以生理相关的方式测试不同遗传背景患者的个体药物反应。